Huge Buzz on $ZFGN as #Zafgen Issues Statement Regarding Patient Death During Phase 3 Trial

Zafgen Issues Statement

UPDATE: READ THE STOCKGURU BUZZ ON ZFGN FOLLOWING THIS ANNOUNCEMENTBOSTON, Oct. 14, 2015 (GLOBE NEWSWIRE) — Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and...